d20 is building on four years of shared learning, connection, and strategic thinking that has helped us better understand the drivers and the key levers for change we can tackle to bend the curve on the diabetes epidemic in America. Our systems analysis has shown us that one of the key barriers to progress on the diabetes issue in America is rooted in stigma and the myths and misunderstandings around diabetes.
We also know that 2020 has been a historic, paradigm-changing and difficult year in this country – cultural, ideological, and narrative divides have been deepening in responses to the COVID-19 health crisis and racial inequities in healthcare and beyond. It is more clear now than ever that understanding how to work across these divides will be essential to bending the diabetes curve.
Our theory of change is that working together to address diabetes stigma in a politically neutral way will be crucial to catalyzing the changes needed across all parts of the diabetes ecosystem – from food and healthcare policy to behavior change amongst patients, those at risk, and healthcare providers. Rooted in lessons from social movements, we know that stigma can be a crippling barrier to policy and behavioral change. We also know that research-based, long-game strategic action to shift our mental models and cultural frames can greatly shift the culture of stigma and directly influence policy - think about the impacts of the frame shift from ‘gay rights’ to ‘marriage equality’, for example.
So this year at d20, we are designing a program in collaboration with some of the foremost experts on framing at the Frameworks Institute that will be focused on shifting the narrative frames contributing to diabetes stigma. Together we will learn about the science of stigma, frame-shifting and behavior change to help us as systems leaders learn to leverage our influence to change norms and challenge assumptions about the causes and care for diabetes in America.
MODULE 1: LEARN about the science of stigma and of changing norms through changing the stories we tell.
MODULE 2: SHAPE shared language - a new narrative - to shift how Americans think, talk, and act about diabetes that will help reduce stigma, increase health, and amplify impact.
MODULE 3: ACT to design personal and collective action plans for how we can share the new narrative in our spheres of influence.
d20 Registration has now closed!
For inquiries about attending, please contact Karena Yan at [email protected].
d20 Participant Biographies
Lions Club International
Diabetes Chair – State of California
Brian Ballard serves as the California Lions Clubs State Diabetes Chair. In this role, he oversees diabetes advocacy, education, and screenings for 15 Lions districts, 700 clubs and over 20,000 Lions clubs’ members throughout the state of California. Lions Clubs International (LCI) is a nonprofit organization with more than 45,000 clubs and 1.3 million members, worldwide that has been in existence for just over 100 years. Since 2017, LCI’s top initiative has been diabetes advocacy. Brian’s outreach work includes partnering with the Lion’s Global Action Team (GAT) to coordinate diabetes projects around the world. GAT is a field team specifically designed to help clubs and district leaders connect with the tools and resources they need to boost their impact on the communities they serve. As a type 1 diabetic for 46 years, Brian well-understands the benefits of diabetes education and enjoys sharing that expertise. He has been professionally involved with diabetes education and support since 1992. Brian is a licensed health insurance broker, having worked with several Medicare Health plans as a Medicare and diabetes outreach coordinator since 1995. He also works with Health Markets serving the needs of Californians. Brian has been a guest speaker for many healthcare events over the years including the JDRF and American Diabetes Association.
Chris Barnes is principal of Emphatic Communications, a design consultancy that helps clients explore complexity, find clarity, and deliver meaningful content that is easy for people to understand and use. Mr. Barnes has over 25 years of experience working with global leaders in healthcare and the life sciences, including clients in diabetes technology. His recent focus has been improving the delivery and experience of health care by making communications tools that better fit human needs. He has worked with teams at Ariadne Labs, the World Health Organization, the CDC, Dana-Farber Cancer Institute, Johns Hopkins, Brigham and Women’s and others to create cognitive aids and decision guides that shape care. Mr. Barnes is co-organizer of Design for Healthcare, a Seattle-based group that brings together a diverse community of designers, providers, payers, patients, and others to explore how human-centered design can drive better patient and clinician experiences and improve outcomes.
Partner and Co-Founder
Dennis Boyle is a Partner and a founding team member of IDEO. Dennis helps lead the Design for Health Studio at IDEO as part of its San Francisco office. Design for Health is the part of IDEO’s business that works with clients in medical and health related industries to develop innovative physical and digital products, software, services and strategies. Over the course of his IDEO career, Dennis has helped us build and nurture many key, long-term client relationships, including Silicon Valley tech firms, Fortune 100 consumer businesses, and health-care companies. He has been named on 55 patents. Dennis is also an adjunct professor at Stanford’s d.school and in the Design Division of the engineering school, where he has taught courses for over 40 years. He established and co-teaches “Design for Healthy Behaviors” at the d.school, a course that draws students from each of the university’s graduate schools. Students in this class learn and use the design thinking process to help patient-volunteers with chronic conditions build healthy behaviors and thrive in their daily lives.Dennis holds a BS in Mechanical Engineering, with an emphasis on Industrial Design, from the University of Notre Dame and an MS in Product Design from Stanford.Dennis enjoys running, road and mountain bicycling and other outdoor sports and can be often seen out on the road and on trails trying to keep up with far younger friends.
American Diabetes Association (ADA)
Chief Executive Officer
Tracey D. Brown is Chief Executive Officer of the American Diabetes Association (ADA), the nation's largest voluntary health organization. Ms. Brown herself has been thriving with type 2 diabetes for over 15 years. She is the first CEO in the organization's almost 80-year history who has type 2 diabetes and is committed to stopping the diabetes epidemic. Ms. Brown joined the ADA in June 2018 after her tenure as Senior Vice President of Operations and Chief Experience Officer at Sam's Club, a division of Walmart, Inc., where she was responsible for creating meaningful member experiences, directing member strategy, marketing and branding, go-to-market execution, data and analytics, and membership operations. Ms. Brown brings more than 25 years of experience in driving global business growth, leveraging data to connect consumers with brands, and creating omni-channel experiences to escalate customer loyalty. She has also served in leadership positions at American Express, Proctor & Gamble, and Exxon Mobil
Primary Care Education Consortium
Executive Vice President
Dr. Brunton is Executive Vice President for Primary Care Education Consortium. He works in a group practice in suburban Los Angeles and holds the faculty rank of Associate Clinical Professor in the Department of Family Medicine at Touro University in Vallejo, California. He currently serves as the Editor-in-Chief for ‘Clinical Diabetes,’ the ADA’s primary care journal, and as the Executive Director of the Primary Care Metabolic Group. Previously, he served as the Director of Education for the American Academy of Family Physicians. Dr. Brunton earned his medical degree at Monash University Medical School in Melbourne, Australia and completed his residency in family practice at Long Beach Memorial Medical Center in California. He is a board-certified family physician, with a certificate of added qualifications in geriatrics.
World Food Policy Center, Duke University
Kelly Brownell is Director of the World Food Policy Center at Duke University, where he is also Robert L. Flowers Professor of Public Policy and Professor of Psychology and Neuroscience. From 2013-2018 he served as Dean of the Sanford School of Public Policy at Duke. Prior to joining the faculty at Duke, Brownell was at Yale University where he was the James Rowland Angell Professor of Psychology, Professor of Epidemiology and Public Health, and Director of the Rudd Center for Food Policy and Obesity. While at Yale he served as Chair of the Department of Psychology and as Head of Silliman College. He has published 15 books and more than 350 scientific articles and chapters, and has served as President of several national organizations. In 2006 Time magazine listed Kelly Brownell among “The World’s 100 Most Influential People” in its special Time 100 issue featuring those “.. whose power, talent or moral example is transforming the world.” Brownell was elected to membership in the National Academy of Medicine (formerly the Institute of Medicine) in 2006 and has received numerous awards and honors for his work, including the Lifetime Achievement Award from the American Psychological Association, Graduate Mentoring Award from Yale, the James McKeen Cattell Award from the New York Academy of Sciences, the Distinguished Alumni Award from Purdue University, the Lifetime Achievement Award from Rutgers University, and the Distinguished Scientific Award for the Applications of Psychology from the American Psychological Association.
The Hangry Woman Blog
Clinical Program Manager
Paula Clinton is a Registered Dietitian and Certified Diabetes Educator. In 2017, she joined Verily and was tasked with developing a coaching program for Onduo, a diabetes virtual care program owned and launched by Verily in January 2018. Onduo leverages tools including the Dexcom continuous glucose monitor and telehealth in app video chat to connect physicians to patients with Type 2 diabetes in order to make the healthcare experience more actionable, accessible and personalized.As a Clinical Program Manager, she runs a clinical trial and product development space that allows Verily to partner with patients with chronic conditions to validate innovative approaches to healthcare products and programs. Through useability and feasibility studies, Verily is able to gain valuable patient insights to inform product development and commercialization.Paula’s previous roles include published researcher at Stanford University in the Department of Pediatric Endocrinology. Paula specialized in artificial pancreas and closed loop technology research working with Dr. Bruce Buckingham and the Jaeb Center for Health Research. As a diabetes subject matter expert and professional speaker, she spent time traveling the US on behalf of the Johnson and Johnson Diabetes Institute (JJDI) educating healthcare professionals on patient and provider management of diabetes. Paula’s true passion is working as part of the medical staff at Diabetes Youth and Families (DYF) Camp for kids with diabetes (16 years strong)!
The diaTribe Foundation | diaTribe.org | Close Concerns
Founder and Chair of the Board | Editor-in-Chief | President
Kelly Close founded The diaTribe Foundation, a nonprofit established in 2013 to improve the lives of people with diabetes and prediabetes and to advocate for action. She is Editor-in-Chief of diaTribe.org, a free educational resource for people with diabetes. Ms. Close founded Close Concerns in 2002; its mission is to make everyone smarter about diabetes. At Close Concerns, Ms. Close and her team write about 3 million words a year on diabetes, prediabetes, obesity, and digital health for Closer Look, a highly praised service covering the field. Ms. Close’s passion comes from her extensive professional work as well as from her personal experience, having had diabetes for over 30 years. Ms. Close’s previous work on Wall Street (investment banking at Goldman Sachs, equity research at Merrill Lynch) and at McKinsey & Company focused on life sciences. Kelly graduated from Amherst College and Harvard Business School.
James Corbett is a seasoned healthcare executive and bioethicist bringing over a decade of chief level leadership experience from both the for-profit and the non-profit sectors of the industry. Mr. Corbett has served as a fellow at Harvard Medical School Department of Global Health and Social Medicine as well as at Harvard’s Safra Center for Ethics; he also recently completed a fellowship at the Nashville Healthcare Council. In addition, he was appointed to a 4-year term on the National Institutes of Health’s National Advisory Council for Nursing Research. He has worked in four health systems, where his focus has been on providing strategic and operational leadership for innovation, behavioral health, population health, research operations, global health, advocacy, and bioethics. Mr. Corbett has also lectured at Harvard Medical School, Harvard’s School of Public Health, and numerous other universities across the country. Mr. Corbett has been published in multiple books and journals. He earned his Bachelor of Science in International Relations from Syracuse University, his Juris Doctorate from St. John’s University, and his Master of Divinity from Duke University.
Marketing & Communications
Stefanie Cousins is a marketing, branding, and communications expert who focuses on food, food policy, and public health. For over five years, Stefanie served as the Director of Marketing and Communications at Brighter Bites. In that role she was responsible for the organization’s corporate communications, strategic marketing, and branding. Before joining Brighter Bites, she provided marketing and communications services to health sector clients including the National Institutes of Health (NIH), the United States Agency for Healthcare Research and Quality (AHRQ), MD Anderson Cancer Center, UNC Health Care, Baylor School of Medicine, and John Snow Inc. (JSI). For 15 years, she was a news and documentary producer for ABC News 20/20, The New York Times, and NOW with Bill Moyers, among others. Ms. Cousins holds an MPH from the University of North Carolina’s Gillings School of Global Public Health and a bachelor’s in English and Italian from Middlebury College. She lives in Austin with her husband and two children.
Project ECHO Diabetes
Dr. Cuttriss is a pediatric endocrinologist and social entrepreneur with a unique dedication to telehealth and improving the quality of life of people living with diabetes. He currently serves as Director of Project ECHO Diabetes and Project ECHO Diabetes in the Time of COVID-19 at Stanford University. Prior to joining Stanford, Dr. Cuttriss served as the first pediatric endocrinologist for the University of New Mexico Project ECHO Institute ENDO teleECHO clinic to democratize diabetes specialty knowledge by empowering primary care providers to care for patients with complex diabetes who lack access to routine diabetes specialty care. Dr. Cuttriss founded ENDO Diabetes & Wellness, a medical practice specializing in diabetes and telehealth. Dr. Cuttriss co-founded and serves as chairman of AYUDA, a global health volunteer organization that empowers youth to serve as agents of change for youth with diabetes. Dr. Cuttriss has special interest in telehealth and supports underserved diabetes communities in the United States and globally.
Diabetes – What To Know
Ansley Dalbo is the CEO and co-founder of Diabetes – What To Know, an online educational resource for people with type 2 diabetes, and My Weight- What To Know, a resource for people living with obesity. She’s passionate about using social media and digital tools to help people thrive through education and support. She’s worked in the diabetes field for almost 20 years, including 13 years spent managing Walmart’s private label diabetes brand, ReliOn. Ansley graduated from Harvard University with a degree in English, and she lives in Atlanta. She’s an avid vegetarian cook, loves playing softball and following the Baltimore Orioles.
Black Diabetic Info
Dr. Phyllisa Deroze is a health humanities scholar, global diabetes patient advocate, and chronic illness lifestyle blogger. She started blogging at diagnosedNOTdefeated.com almost immediately after being diagnosed with diabetes in 2011. The following year, Dr. Deroze founded Black Diabetic Info™ (a website that situates diabetes information within the cultural beliefs and practices of the African diaspora) because she felt important aspects of her lived experiences were inadequately addressed in the diabetes information she encountered. Dr. Deroze has graced the cover of Health Monitor magazine and has been featured in Diabetic Living and Diabetes Focusmagazines. Her research includes analyzing health narratives in literature, drama, and popular culture. Her current project examines the representation of African American characters with diabetes in television and film. Dr. Deroze’s passion for diabetes advocacy is evident through her YouTube vlogs, social media posts, in-person workshops, and keynote speeches that she has given in five countries.
Associate Director of Alliance Development
Meredith Dyer is the Associate Director of Alliance Development at Novo Nordisk. Prior to joining Novo Nordisk, Meredith was the Director of Health Policy at the Endocrine Society from 2010-2020 where she worked on legislative and regulatory issues related to diabetes, obesity, and Medicare coverage. In this capacity, Meredith served as an advocate on Capitol Hill and with federal agencies to improve public health and managed strategic relationships with trade associations, patient advocacy groups, and industry partners. Meredith was co-chair of the Diabetes Advocacy Alliance and Obesity Care Advocacy Network where she worked closely with the public affairs team. Additional advocacy experience includes work with The Clinton Group, The National Association for Behavioral Health, and the American Association of Political Consultants. Meredith received a B.A. from the George Washington University in political science and psychology and a M.A. from Johns Hopkins University in government and political communications.
GENEVIEVE JEAN-BART FADAYOMI
Associate Director of US Corporate Sustainability & Social Impact
Genevieve Jean-Bart Fadayomi is a corporate social responsibility and marketing professional with over 14 years of experience in the pharmaceutical industry. In her role as Associate Director of U.S. Corporate Sustainability & Social Impact at Novo Nordisk, she is focused on the development and implementation of social impact strategy and community outreach initiatives. She leads signature program efforts for the organization, which provides grants to 501c3 organizations pursuing innovative, community-based approaches to improving health outcomes by promoting healthy communities and decreasing health disparities.
Mark Fischer-Colbrie became CEO of Strateos in May 2019 following the successful sale of Labcyte Inc., a global laboratory tools company, to Danaher. He has more than 30 years of experience in building and growing laboratory tools, diagnostic, medical device and therapeutic companies, including 3 Initial Public Offerings. In 2013, Mark was named National Finalist, Life Sciences for the Ernst & Young National Entrepreneur of the Year and Entrepreneur of the Year, Life Sciences for Northern California. Prior to Strateos, Mark was CEO for over ten years at Labcyte Inc. which invented novel lab tools and automation based on acoustic dispensing. Before Labcyte, Mark ran business development and was CFO at Adeza Biomedical Corporation, a women’s healthcare company, where he filed 9 patent applications and set up and ran clinical trials for diagnostics. Prior to Adeza, Mark was the CFO for 9 years for a vision correction company that went public and launched a Class III medical device. Mark holds a BA from Stanford and an MBA in marketing / finance from UC Berkeley. Mark has served as Chairman of JDRF’s International Board of Directors, the largest global funder of type one diabetes research, and served on the JDRF IBOD for seven years. Mark has also served on the industry board of the Analytical, Life Sciences Diagnostics Association (ALDA) since 2011. Mark enjoys participating in long distance triathlon and running events.
Houston Health Department
Dr. Faith Foreman-Hays is an Assistant Director at the Houston Health Department. She is seasoned public health practitioner and academician with more than 20 years of community and coalition building experience. In 2013, Dr. Foreman-Hays was tapped to lead the Cities Changing Diabetes (CCD) Global Public-Private Partnership aimed at reducing the burden of diabetes in urban populations. As the Assistant Director of the Houston Health Department, Dr. Foreman-Hays leads adynamic team of nurses, health educators, wellness professionals, health planners, and dieticians. Dr. Foreman-Hays has a special passion for reducing health disparities among marginalized communities. Currently, she leads the City of Houston’s COVID-19 Better. Together. public health education and outreach intervention. Dr. Foreman-Hays earned her masters and doctorate in public health from the University of Texas School of Public Health, and her bachelor’s in sociology from Texas Southern University. She was also a National Institutes of Health Fellow. Dr. Foreman-Hays is licensed to practice nursing in Texas.
American Diabetes Association
Chief Scientific and Medical Officer
Robert A. Gabbay, MD, PhD is Chief Scientific and Medical Officer of the American Diabetes Association and Associate Professor at Harvard Medical School and recently transition from his role as Chief Medical Office at the Joslin Diabetes Center. His research focuses on innovative models of diabetes care to improve to enhance diabetes outcomes and improve the lives of people with diabetes. To meet these goals, he has traversed many arenas including an initial career as a basic scientist researcher to development of better patient communication tools, creating the first broad scale diabetes registry, designing and implementing a care management training program, leading one of the largest primary care transformation efforts in the US around the Patient Centered Medical Home and defining the medical neighborhood and the role of centers of excellence in diabetes and envisioning the digital health as the latest member of the diabetes team. The reach of his work has been recognized through leadership roles in national and international activities to transform diabetes care including leading the International Diabetes Federation BRIDGES program that implements evidence based translational research to low resource global settings Dr. Gabbay has received funding from the National Institute of Health Diabetes, Digestive and Kidneys Diseases (NIDDK), the Agency for Healthcare Research and Quality (AHRQ), and the Center for Medicare and Medicaid Innovation for his care transformation work. Along with an extensive peer reviewed publication record, his views have appeared in popular press such as the New York Times, CNN, the Washington Post, People, Oprah, and National Public Radio.
JAMES R. GAVIN III
Healing Our Village, Inc.
Chief Medical Officer
Dr. James R. Gavin is a clinical professor of medicine at Emory University School of Medicine and at the Indiana University School of Medicine. He currently serves as Chief Medical Officer of Healing Our Village, Inc. Previously, he was president of the Morehouse School of Medicine in Atlanta. He served as senior scientific officer at the Howard Hughes Medical Institute and as director of the HHMI–National Institutes of Health Research Scholars Program. Dr. Gavin belongs to a number of organizations, including the National Academy of Medicine (formerly the IOM), the American Diabetes Association, the American Association of Clinical Endocrinologists, the American Society of Clinical Investigation, and the American Association of Physicians. He is a past president of the ADA and has been voted Clinician of the Year in Diabetes by the ADA multiple times. Dr. Gavin was named a “Living Legend in Diabetes” by the American Association of Diabetes Educators in 2009 and was named one of the “175 Emory History Makers” on the celebration of the University’s 175th Anniversary. In 2015, he received a Lifetime Achievement Award for Diabetes Research from ADA, and the Lifetime Meritorious Achievement Award from the NMA. Dr. Gavin has a MD from the Duke University School of Medicine and a PhD in Biochemistry from Emory University.
Jasvinder (Jas) Gill is the medical director for Insulins for General Medicines, at Sanofi, US. Jas is part of the larger diabetes medical team in the US responsible for data generation and publications, with a focus on patients' unmet needs and barriers to technology in diabetes management. Jas has worked in healthcare for over 20 years and was actively involved in the launch of Lantus and Toujeo in the US. Currently, Jas is involved in the Type 1 study using CGM technology known as the IN RANGE trial evaluating TIR. She is passionate about people with diabetes and trying to understand key challenges in diabetes management. She has her PhD in pathology from the University of London, and experience in clinical development and medical affairs as well as several authored publications in the field of diabetes.
Robert Greene is the CEO/Principal of Cedar & Burwell Strategic Consulting, specializing in the application of DEI technologies in broad-scale organizational development consulting. Prior to Cedar & Burwell, Robert served as a teacher and administrator in educational organizations, department leader in for-profit organizations, trustee and director for non- profit and social entrepreneurship agencies, and consultant to corporate and civic enterprises. He brings insightful thinking, writing and consulting to issues ranging from organizational development and leadership design; diversity and inclusion leadership and management strategies; human resources and organizational culture consulting; wealth and social class disparities; the impact of identity differences in employee culture; and bias awareness and bias resistance training to his current professional engagements. Robert has also been a peer reviewer for one of the most exciting recent contributions in social psychology around unconscious bias, The Person You Mean to Be: How Good People Fight Bias, by Dolly Chugh.
Divya Gopisetty is currently a student at Stanford School of Medicine, pursuing a dual MD/MPH degree to support her advocacy for community-based health reform. Divya approaches her work and life by listening with intention and challenging the status quo. In 2018, she co-created a program called Disrupt Diabetes, where people living with diabetes led high-impact teams of healthcare professionals, industry leaders, and designers to develop solutions to unmet needs in diabetes. Prior to medical school, Divya worked at The diaTribe Foundation as a Senior Associate. Here, she organized d19, wrote for diaTribe Learn, and spoke on behalf of patients at national meetings. In her free time, Divya loves to dance - for two years, she was part of Duniya Dance & Drum, an Indian and West African dance company that creates pieces rooted in social justice. At d20, Divya is very much looking forward to bringing a frame of justice, revolutionary love, and imagination to the narratives around diabetes.
Jennifer Hahamian is a Marketing and Business Development Consultant with a focus on the Consumer and Professional Medical Device Markets. Jennifer Hahamian Consulting specializes in marketing diabetes products, diagnostics, and remote patient management. The companies she serves benefit from her experiences from two venture capital-backed diabetes device startup companies, and 19 years at Johnson & Johnson as the VP of Marketing and e-business. Ms. Hahamian is grounded in all aspects of healthcare marketing and business development including point of care diagnostics, direct to consumer marketing, hospital products, retail/pharmacy distribution, new product launches, and opportunity evaluations. She holds a BSc in Accounting from Santa Clara University and an MBA in Marketing and Management from San Jose State University.
Scott is an experienced patient advocate who has worked with a wide range of stakeholders across the healthcare environment to help them establish effective communication with the patient community. His expertise in the diabetes social media space is recognized worldwide. Today he manages patient success for mySugr North America and continues to run his long-standing and award-winning blog “Scott's Diabetes” as time allows. Scott is also a member of the Children with Diabetes faculty where he develops educational curriculums and content for the Friends for Life annual conference and regional events. He served on the Executive Committee of the Board of Directors for the Diabetes Hands Foundation and was a founding member of Partnering for Diabetes Change, a coalition of people living with diabetes and industry representatives working to support culturally diverse and underserved communities. He is interested in how these types of interactions, including peer-to-peer support, impact patient outcomes and routinely presents his work.
David G. Marrero, PhD, is the director of the UA Center for Health Disparities Research at the University of Arizona Health Sciences. The Center works to develop programs and strategies to improve health and wellbeing along the U.S.-Mexico border and across the greater Southwest. Dr. Marrero, also is professor of public health at the UA Mel and Enid Zuckerman College of Public Health, Department of Health Promotion Sciences, and professor in the UA College of Medicine – Tucson, Department of Medicine, Division of Endocrinology. Twice awarded the Allene Von Son Award for Diabetes Patient Education Tools by the American Association of Diabetes Educators, Dr. Marrero has been nominated to Who’s Who in Medicine and Health Care in 2000, served as associate editor for Diabetes Care (1997-2002) and is the associate editor for Diabetes Forecast. He was selected for an Alumni of the Year award from the University of California, Irvine in 2006 and Outstanding Educator in Diabetes in 2008 by the American Diabetes Association. In 2016, he served as the President for Health Care and Education of the American Diabetes Association. His research interests also include strategies for promoting diabetes prevention, improving diabetes care practices used by primary care providers and the use of technology to facilitate care and education. His clinical interests include diabetes, obesity and coping.
Joe Nadglowski is President & CEO of the Obesity Action Coalition (OAC) – a nonprofit organization formed in 2005 dedicated to elevating and empowering individuals affected by obesity through education, advocacy and support. A frequent speaker and author, Mr. Nadglowski is especially passionate about access to obesity treatments, tackling weight bias and sharing his own experiences with obesity. He has more than 25 years of experience working in patient advocacy, public policy and education and is a graduate of the University of Florida.
Marla had been a passionate T1D advocate ever since her two sons were diagnosed as children. Over the past 25 years, she has invested in and helped nurture companies and organizations centered around improving the lives of those living with diabetes both T1D/T2D. Her involvement includes angel investing, forging strategic partnerships, advising on how to maximize marketing initiatives and garner awareness for the cause and the supporting organizations. Marla is the Executive Producer of the T1D documentary “The Human Trial”, on the Leadership Council for “Beyond Type 1” and a volunteer for JDRF. Marla is always looking for new opportunities and collaborations. She is interested in expanding her professional and philanthropic network.
The diaTribe Foundation/Amylin Pharmaceuticals
Board Member/Former Chief Financial Officer
Marjorie Sennett’s strategic business skills in the diabetes industry stem from her roles as an operating executive and an institutional investor. As the Chief Financial Officer of Amylin Pharmaceuticals for nine years, she raised $400 million enabling the company’s early development of three novel drugs for diabetes. As a former Managing Director of Farallon Capital, she managed a $700 million portfolio of investments in biopharmaceutical, medical device, and diagnostic companies, including several in the diabetes industry. She understands the complexities of the diabetes ecosystem, the operational challenges of building entrepreneurial companies, and the return expectations of institutional investors. During 2014-2018, she served as a member of the Board of Directors and Audit Committee of QuinStreet, a publicly-traded performance marketing technology company. Since 2017, she has served on the Board of Directors of The diaTribe Foundation and is Chair of its Audit Committee. Ms. Sennett earned an MBA from the Stanford Graduate School of Business and a BA, magna cum laude, in Biology and English from Vanderbilt University.
Brighter Bites/University of Texas School of Public Health
The diaTribe Foundation
Larry Soler founded Convergency, an advocacy and marketing firm focused on health, wellness, and nutrition. Prior to Convergency, Mr. Soler was a senior executive at two leading mission-driven organizations. At the Juvenile Diabetes Research Foundation (JDRF), he built an advocacy program that was cited as among the most powerful in Washington DC. Mr. Soler chaired the successful national campaign to advance stem cell research, and he secured more than $2 billion in mandatory federal diabetes funding, the only disease area to get such funding. He went on to serve as Chief Operating Officer with oversight responsibility for most major activities within the organization. Following his time at JDRF, Mr. Soler served as CEO for the Partnership for a Healthier America, where he worked with PHA Honorary Chair Michelle Obama and PHA Vice Chairs Senator Cory Booker and former Senator Bill Frist on corporate partnerships. Mr. Soler developed more than 250 such partnerships and raised more than $50 million during his time at PHA. Mr. Soler earned a BA in American Government and Politics from Clark University and a JD from George Washington University.
Lee Strasberg Institute
Sanjay Trehan is Business Development Project Leader at Genentech, where he leads strategic collaborations, acquisitions, and partnering efforts across the Genentech portfolio. Mr. Trehan has been responsible for licensing deals with an aggregate value of over $1 billion and these activities have resulted in successful co- development programs, collaborative commercialization, and the research and development of products from preclinical research to late stage development. Prior to Genentech, Mr. Trehan held corporate development roles at Sanofi Genzyme, including leading Business Development for Genzyme’s Global Rare Disease business unit. He started his career at Close Concerns, overseeing the pharmaceutical coverage of the Closer Look publication. Mr. Trehan holds BS in Computational Biology from Brown University and an MBA from the MIT Sloan School of Management.
Virginia Valentine is a Diabetes Specialist with Clinica La Esperanza in Albuquerque, New Mexico. She is also a faculty clinician with Endo Echo with University of New Mexico. Project ECHO (Extension for Community Healthcare Outcomes) is a collaborative model of medical education and care management that empowers clinicians across New Mexico to provide better care to more people, right where they live. Ms. Valentine received her master’s in nursing from the University ofOklahoma College of Nursing. She is board-certified in Advanced Diabetes Management and is a Certified Diabetes Educator. In 2006, the American Association of Diabetes Educators recognized her with its Distinguished Service Award and awarded her Fellow status in 2010. Ms. Valentine has been awarded the 2019 Outstanding Educator in Diabetes by the American Diabetes Association. She has been living well with type 2 diabetes for over 35 years.
Richard Wood is CEO of dQ&A, the diabetes market research company that he founded with Kelly and John Close in 2009. dQ&A focuses on helping companies understand the diabetes patient and healthcare provider landscapes through syndicated and custom research programs. Mr. Wood was previously Vice President of Consumer Insights at Nielsen, where he managed all consumer market research programs for the mobile telecoms industry in the USA, Europe, and Asia. He has extensive experience from a 20-year career in consumer and industry research, software, and publishing; and he holds an MBA from INSEAD.
Thank you to our sponsors: